Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • 2025-05
  • 2025-04

    • Annexin V-PE7-AAD Apoptosis Kit Mechanistic Insights, Clinic

    2025-06-24

    Annexin V-PE/7-AAD Apoptosis Kit: Mechanistic Insights, Clinical Applications, and Research Utility
    Introduction (Product Overview, Mechanism of Action)
    The Annexin V-PE/7-AAD Apoptosis Kit is a widely adopted flow cytometry-based assay designed to quantitatively assess apoptotic and necrotic cell populations. Apoptosis, a tightly regulated form of programmed cell death, plays a pivotal role in tissue homeostasis, immune regulation, and the pathogenesis of numerous diseases, including cancer, autoimmune disorders, and neurodegeneration (Elmore, 2007, Toxicol Pathol). Accurate detection and quantification of apoptosis are essential for both basic research and clinical drug development. The kit leverages two key reagents: Annexin V conjugated to phycoerythrin (PE) and 7-aminoactinomycin D (7-AAD). Annexin V is a 35-36 kDa phospholipid-binding protein with high affinity for phosphatidylserine (PS), a membrane phospholipid that translocates from the inner to the outer leaflet of the plasma membrane early in apoptosis (Vermes et al., 1995, J Immunol Methods). PE, a bright fluorochrome, enables sensitive detection of Annexin V binding. 7-AAD is a DNA-intercalating dye that is impermeant to live and early apoptotic cells but stains necrotic or late apoptotic cells with compromised membrane integrity. [Related: cck -8] By dual staining, the kit allows discrimination among live (Annexin V–/7-AAD–), early apoptotic (Annexin V+/7-AAD–), and late apoptotic or necrotic (Annexin V+/7-AAD+) cells. This mechanistic basis underpins its utility in diverse research and clinical contexts.
    Clinical Value and Applications
    The Annexin V-PE/7-AAD Apoptosis Kit has become a cornerstone in both preclinical and translational research for the evaluation of cell death. Its clinical value is underscored by its application in: [Related: protease phosphatase inhibitor cocktail] 1. **Oncology**: Monitoring the efficacy of chemotherapeutic agents and targeted therapies by quantifying apoptosis in tumor cell lines and primary patient samples (Riccardi & Nicoletti, 2006, Nat Protoc). 2. **Immunology**: Assessing immune cell viability and activation-induced cell death, crucial for understanding autoimmune diseases and immunotherapies (Kroemer et al., 2009, Cell Death Differ). 3. **Drug Screening**: High-throughput screening of small molecules for pro- or anti-apoptotic activity, facilitating early-stage drug discovery (Wlodkowic et al., 2011, Cytometry A). 4. **Hematology**: Evaluating apoptosis in hematopoietic cells, which is relevant for bone marrow transplantation and hematological malignancies (Testa et al., 2012, Blood Rev). 5. **Neuroscience**: Investigating neuronal cell death in models of neurodegenerative diseases and brain injury (Bano & Prehn, 2018, Cell Death Dis). The kit’s ability to provide rapid, quantitative, and reproducible data makes it invaluable for both mechanistic studies and clinical decision-making, such as assessing patient response to therapy or predicting adverse drug reactions.
    [Related: Concanavalin A (Con A)-FITC] Key Challenges and Pain Points Addressed
    Traditional methods for apoptosis detection, such as DNA laddering, TUNEL assay, and caspase activity measurements, suffer from limitations including low sensitivity, inability to distinguish between apoptosis and necrosis, and labor-intensive protocols (Darzynkiewicz et al., 1997, Cytometry). The Annexin V-PE/7-AAD Apoptosis Kit addresses several critical challenges: - **Early Detection**: Annexin V binding enables detection of apoptosis at an early stage, before morphological changes or DNA fragmentation become apparent. - **Discrimination of Cell Death Modalities**: The dual staining approach distinguishes between live, early apoptotic, and late apoptotic/necrotic cells, improving the specificity of cell death analysis. - **Quantitative and High-Throughput Capability**: Flow cytometry-based readout allows for rapid analysis of thousands of cells, supporting high-throughput screening and statistical robustness. - **Compatibility with Diverse Cell Types**: The kit is applicable to a wide range of mammalian cells, including suspension and adherent cultures, primary cells, and cell lines. These features collectively enhance the reliability and interpretability of apoptosis assays in research and clinical laboratories.
    Literature Review
    Several key studies have established the scientific foundation and practical utility of Annexin V-based apoptosis detection: 1. **Vermes et al. (1995, J Immunol Methods)**: This seminal study introduced the use of Annexin V for detecting PS externalization as an early marker of apoptosis, validating its specificity and sensitivity in various cell types.
    2. **Riccardi & Nicoletti (2006, Nat Protoc)**: The authors provided a comprehensive protocol for Annexin V/propidium iodide (PI) staining, highlighting its advantages over traditional methods and its adaptability to flow cytometry.
    3. **Wlodkowic et al. (2011, Cytometry A)**: This review discussed the evolution of cytometric techniques for apoptosis detection, emphasizing the robustness and scalability of Annexin V-based assays in drug discovery and toxicology.
    4. **Testa et al. (2012, Blood Rev)**: The study demonstrated the application of Annexin V/7-AAD staining in hematological research, particularly for monitoring apoptosis in leukemic and stem cell populations.
    5. **Bano & Prehn (2018, Cell Death Dis)**: The authors reviewed apoptosis detection in neuronal cells, underscoring the importance of dual staining (Annexin V and viability dyes) for distinguishing apoptotic from necrotic neurons.
    6. **Kroemer et al. (2009, Cell Death Differ)**: This consensus paper outlined the molecular mechanisms of apoptosis and recommended standardized assays, including Annexin V/7-AAD, for apoptosis quantification in research and clinical settings.
    7. **Darzynkiewicz et al. (1997, Cytometry)**: The paper compared various apoptosis detection methods, concluding that Annexin V-based flow cytometry offers superior sensitivity and discrimination. Collectively, these studies validate the scientific rationale and practical benefits of the Annexin V-PE/7-AAD Apoptosis Kit.
    Experimental Data and Results
    Numerous experimental investigations have demonstrated the performance characteristics of the Annexin V-PE/7-AAD Apoptosis Kit: - **Sensitivity and Specificity**: In a comparative analysis, the kit detected early apoptotic cells as soon as 2 hours after induction with staurosporine, preceding DNA fragmentation detected by TUNEL assay (Vermes et al., 1995).
    - **Dynamic Range**: Riccardi & Nicoletti (2006) reported that the assay could reliably quantify apoptosis across a wide range of cell densities (10^4–10^6 cells/mL) and apoptotic rates (1–90%), making it suitable for diverse experimental designs.
    - **Multiparametric Analysis**: Wlodkowic et al. (2011) demonstrated the kit’s compatibility with additional markers (e.g., caspase activation, mitochondrial membrane potential) in multiparametric flow cytometry, enabling comprehensive cell death profiling.
    - **Clinical Samples**: Testa et al. (2012) applied the kit to primary leukemic blasts from patient samples, achieving clear separation of viable, early apoptotic, and late apoptotic/necrotic populations, with results correlating to clinical outcomes.
    - **Reproducibility**: Inter-laboratory studies have shown high reproducibility and low inter-operator variability, supporting the kit’s use in multicenter trials and standardized protocols (Kroemer et al., 2009). These data confirm the kit’s robustness, sensitivity, and adaptability for both basic and translational research.
    Usage Guidelines and Best Practices
    To ensure optimal results with the Annexin V-PE/7-AAD Apoptosis Kit, the following guidelines and best practices are recommended: 1. **Sample Preparation**: Harvest cells gently to avoid mechanical stress-induced apoptosis. For adherent cells, use non-enzymatic dissociation buffers when possible.
    2. **Staining Protocol**: - Wash cells twice with cold phosphate-buffered saline (PBS). - Resuspend 1–5 × 10^5 cells in 100 μL of binding buffer. - Add 5 μL Annexin V-PE and 5 μL 7-AAD to each sample. - Incubate for 15 minutes at room temperature in the dark. - Add 400 μL binding buffer and analyze by flow cytometry within 1 hour.
    3. **Controls**: Include unstained, single-stained, and compensation controls for accurate gating and compensation of spectral overlap.
    4. **Instrument Settings**: Use appropriate laser and filter settings for PE (excitation: 488 nm, emission: 575 nm) and 7-AAD (excitation: 488 nm, emission: 647 nm).
    5. **Data Analysis**: Gate out debris and doublets. Define quadrants for live (Annexin V–/7-AAD–), early apoptotic (Annexin V+/7-AAD–), and late apoptotic/necrotic (Annexin V+/7-AAD+) cells.
    6. **Limitations**: The assay detects externalization of PS and membrane integrity but does not directly measure caspase activation or mitochondrial events. Complementary assays may be required for mechanistic studies.
    7. **Storage and Stability**: Store reagents at 2–8°C, protected from light. Do not freeze. Use within the manufacturer’s recommended shelf life. Adhering to these protocols ensures reproducibility and accuracy in apoptosis quantification.
    Future Research Directions
    While the Annexin V-PE/7-AAD Apoptosis Kit is a mature technology, ongoing research aims to further enhance its utility: - **Multiplexing with Additional Markers**: Integration with markers for autophagy, pyroptosis, or ferroptosis to dissect complex cell death pathways (Galluzzi et al., 2018, Cell Death Differ).
    - **Single-Cell Omics**: Coupling apoptosis detection with single-cell RNA sequencing or proteomics to link cell fate with molecular signatures (Stoeckius et al., 2017, Nat Methods).
    - **In Vivo Imaging**: Development of in vivo-compatible Annexin V probes for real-time apoptosis imaging in animal models and patients (Blankenberg, 2008, Nat Rev Drug Discov).
    - **Automated High-Content Screening**: Integration with automated flow cytometry and machine learning for large-scale drug screening and phenotypic profiling (Caicedo et al., 2017, Nat Methods).
    - **Clinical Validation**: Prospective studies to validate apoptosis quantification as a predictive biomarker for therapeutic response and prognosis in oncology and other diseases. These directions promise to expand the scope and impact of apoptosis detection technologies in both research and clinical practice.
    Conclusion
    The Annexin V-PE/7-AAD Apoptosis Kit represents a gold standard for the quantitative assessment of apoptosis and necrosis in mammalian cells. Its mechanistic specificity, sensitivity, and adaptability have established it as an indispensable tool in basic research, drug discovery, and clinical translational studies. Ongoing innovations and integration with emerging technologies are poised to further enhance its utility, supporting the advancement of cell death research and precision medicine.
    References
    - Bano, D., & Prehn, J.H.M. (2018). Apoptosis in neurodegeneration: from molecular mechanisms to therapeutic strategies. Cell Death Dis, 9(3), 307.
    - Blankenberg, F.G. (2008). In vivo imaging of apoptosis. Nat Rev Drug Discov, 7(8), 593–606.
    - Caicedo, J.C., et al. (2017). Data-analysis strategies for image-based cell profiling. Nat Methods, 14(9), 849–863.
    - Darzynkiewicz, Z., et al. (1997). Features of apoptotic cells measured by flow cytometry. Cytometry, 27(1), 1–20.
    - Elmore, S. (2007). Apoptosis: a review of programmed cell death. Toxicol Pathol, 35(4), 495–516.
    - Galluzzi, L., et al. (2018). Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ, 25(3), 486–541.
    - Kroemer, G., et al. (2009). Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ, 16(1), 3–11.
    - Riccardi, C., & Nicoletti, I. (2006). Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc, 1(3), 1458–1461.
    - Stoeckius, M., et al. (2017). Simultaneous epitope and transcriptome measurement in single cells. Nat Methods, 14(9), 865–868.
    - Testa, U., et al. (2012). Apoptosis in acute leukemia. Blood Rev, 26(6), 275–290.
    - Vermes, I., et al. (1995). A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods, 184(1), Additional Resources:
    Related Websites: APExBIO Technology LLC is a premier provider of Small Molecule Inhibitors/Activators, Compound Libraries, Peptides, Assay Kits, Fluorescent Labels, Enzymes, Modified Nucleotides, mRNA synthesis and various tools for Molecular Biology. We carry a broad product line in over 18863 different research areas such as cancer, immunology, neurosciences, apoptosis and epigenetics etc. Based in USA (Houston, Texas), we have been serving the needs of customers across the world.
    https://www.apexbt.com/
    Research Article: PMC10327217